XML 28 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Stock Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense stock options and restricted stock
   Three Months
Ended
September 30,
2020		   Nine Months
Ended
September 30,
2020		   Three Months
Ended
September 30,
2019		   Nine Months
Ended
September 30,
2019		 
Research and development  $34,430   $78,035   $—   $— 
General and administrative   511,690    1,189,285    (229,016)   378,607 
   $546,120   $1,267,320   $(229,016)  $378,607 
Schedule of fair value of employee stock options
    Nine Months Ended
September 30,
2020		  
Weighted average exercise price   $ $10.13  
Weighted average grant date fair value   $ $9.02  
Assumptions        
Expected volatility     87-91 %
Expected terms (in years)     6.3-10  
Risk-free interest rate     0.36-1.47 %
Expected dividend yield     0.00 %
Schedule of stock option activity
   Number of
Shares		   Weighted-
Average
Exercise
Prices		   Weighted-
Average
Remaining
Contractual
Term (In Years)		   Intrinsic
Value		 
Outstanding at January 1, 2020   2,139,078   $3.46    9.17   $4,052,512 
Granted   752,045    10.13    —    — 
Cancelled   (20,000)   5.24    —    — 
Outstanding at September 30, 2020   2,871,123   $5.19    8.75   $38,128,217 
Exercisable at September 30, 2020   750,355   $2.51    7.90   $11,979,107